Announcements Trials

Browse Landscape

Phase

Status

Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Renal Cell 20 Neoplasm Metastasis 12 Prostatic Neoplasms 11 Neoplasms 8 Carcinoma, Hepatocellular 8 Carcinoma, Non-Small-Cell Lung 5 Breast Neoplasms 5 Colorectal Neoplasms 4 Pancreatic Neoplasms 3 Ovarian Neoplasms 3 Liver Neoplasms 3 Carcinoma, Transitional Cell 3 Urinary Bladder Neoplasms 2 Triple Negative Breast Neoplasms 2 Recurrence 2 Pheochromocytoma 2 Paraganglioma 2 Neuroendocrine Tumors 2 Multiple Myeloma 2 Melanoma 2 Kidney Neoplasms 2 Fallopian Tube Neoplasms 2 Carcinoma, Medullary 2 Carcinoid Tumor 2 Brain Neoplasms 2 Adenocarcinoma 2 Uveal Melanoma 1 Uterine Cervical Neoplasms 1 Urothelial Cancer 1 Urethral Neoplasms 1

Interventions

temsirolimus 1 selpercatinib 1 pralsetinib 1 cabozantinib 1 acetaminophen, codeine drug combination 1 Vitamin B 12 1 Tramadol 1 Thyrotropin-Releasing Hormone 1 Thyroidectomy 1 Thyroid (USP) 1 Sorafenib 1 Pemetrexed 1 Panobinostat 1 Observation 1 Negative-Pressure Wound Therapy 1 NAc-Sar-Gly-Val-(d-allo-Ile)-Thr-Nva-Ile-Arg-ProNEt 1 Metformin 1 Lysine Acetyltransferase 5 1 Iodine-131 1 Folic Acid 1 Fluorescein 1 Data Collection 1 Congresses as Topic 1 Cisplatin 1 Cetuximab 1 Capsules 1 Blood Cell Count 1 Biopsy, Needle 1 Acetaminophen 1 AZD 6244 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Thyroid Diseases × cabozantinib × Clear all

NCT05660954 2026-05-04

CABOTHYROID

Grupo Espanol de Tumores Neuroendocrinos

Phase 2 Completed

Neoplasms, Thyroid Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡